Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study).

Sigismond LasockiThibault LoupecElsa Parot-SchinkelBruno VielleMarc Danguy des DésertsAntoine RoquillyMaria Lahlou-CasulliVincent CollangeOlivier DesebbeAlexis DuchalaisBertrand DrugeonPierre BouzatDelphine GarrigueBenjamin MounetFranck HamardJean-Stéphane DavidMaxime LegerEmmanuel Rineaunull null

Published in: BMJ open (2021)

clinicalTrials.gov identifier: NCT02972294; EudraCT Number 2016-003087-40.

Keyphrases

hip fracture
end stage renal disease
study protocol
ejection fraction
chronic kidney disease
prognostic factors
low dose
iron deficiency